Global Basal Cell Carcinoma Treatment Market To grow to around USD 12.8 billion by 2028

The global basal cell carcinoma treatment market had total revenues of roughly USD 5.53 billion in 2021 and is predicted to grow to around USD 12.8 billion by 2028, with a CAGR of around 8.1 percent.

Basal cell carcinoma is one of the most common forms of skin cancer and also one of the most frequently occurring among all forms of cancer. BCC grows slowly and hence is treatable if caught during the early stages of development. Basal cell carcinoma occurs when the top layer of the skin i.e. epidermis undergoes DNA damage due to prolonged exposure to UV rays or indoor tanning activities. Symptoms of BCC vary from person to person but generally, they look like pink growth on the skin, red patches, open pores, rolled edges, or growth with slight elevation on the skin. This type of skin cancer generally does not spread beyond the original tumor site, but if these lesions are not controlled in the easy stages they may grow to become dangerous or disfiguring.

The disease is treated with surgery to remove the entire cancerous cell or the unhealthy part of it. The global basal cell carcinoma treatment market is propelled by medical treatments like electrosurgery, excisional surgery, radiation therapy, Mohs surgery, cryosurgery, laser surgery, topical medications, and medications for advanced BCC.

The global market growth was halted during the initial phase of Covid-19 owing to all efforts being directed towards containing, controlling, and treating Covid-19-related issues. However, the demand for BCC treatment was still high given the seriousness of the disease and the constant medical attention it needs.

As per a 2021 report published by The Skin Cancer Foundation, around 3.6m of the American population is diagnosed with the disease annually. This trend is observed in other parts of the world as well where BCC has proven to be the most common form of all cancers. The rising number of skin disorders or BCC patients is expected to propel the global basal cell carcinoma treatment market during the forecast period. There is also a rise in the number of cuticular malignancies and the geriatric population which is easily prone to such diseases. This when coupled with a surging number of medical facilities offering treatment for BCC is projected to aid the global market growth. With changes in climatic conditions and increasing pollution index, the harmful UV rays have become more dangerous in current times. Along with this, there is a lack of awareness in remote areas of underdeveloped countries about proper precautionary measures against the adverse effects of UV rays. This is projected to raise the number of carcinogenic patients in the coming years and assist in the global market expansion.

The high cost of basal cell carcinoma treatment is a restraining factor in the global market growth but heavy investments and extensive R&D by key market players may provide growth opportunities. The global market expansion may face challenges in the tedious management of high-risk and advanced BCC cases.

The global basal cell carcinoma treatment market is categorized into treatment type, end-user, and region. Based on the treatment type, the global market is divided into radiation therapy, drugs, and surgery. The end-user segment consists of specialty clinics, hospitals, and others.

The global basal cell carcinoma treatment market is expected to be dominated by North America in the coming years. North America has registered the highest number of basal cell carcinoma patients in the last few years. This may be aided by the extensive awareness amongst the general population about the diseases and subsequent regular check-ups. The healthcare facilities in the region are known worldwide. The patient-friendly medical reimbursement policies are expected to aid the regional market growth.

Asia Pacific is expected to register a high CAGR during the forecast period because of the growing number of medical facilities offering affordable treatment for the disease alongside the rise in funding groups providing necessary funds to the underprivileged sectors in the region.

The major players operating in the global basal cell carcinoma treatment market include Sun Pharmaceuticals Ltd, Mylan N.V., F. Hoffmann-La Roche Ltd., Valeant Pharmaceuticals International Inc, Merck and Co. Inc., Sanofi, Strides Arcolab Ltd., Perrigo Company plc, Allergan, Inc., and Bausch Health Companies among others.

Recent Developments:

• In June 2021, Sanofi and Regeneron’s PD-1 inhibitor Libtayo® has received approval from the European Commission to treat people with locally advanced or metastatic basal cell carcinoma who have advanced or are intolerant to a Hedgehog pathway inhibitor.

Browse the full “Basal Cell Carcinoma Treatment Market By Treatment Type (Radiation Therapy, Drugs, And Surgery), By End-User (Specialty Clinics, Hospitals, And Others), And By Region – Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/basal-cell-carcinoma-treatment-market

Global basal cell carcinoma treatment market is segmented as follows:

By Treatment Type

• Surgery
• Drugs
• Radiation Therapy

By End User

• Hospitals
• Specialty Clinics
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com